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Abstract
The present study was conducted to determine the effect of differential endogenous
estrogen exposure in rats on stress-induced changes in spatial working memory. Subjects
comprised male (n=8) and female (n=10) Sprague-Dawley rats, which were trained to
complete a T maze, delayed alternation task. Performance was scored as a percentage of
trials during which the correct maze arm was selected. Subjects’ scores were recorded
after 1 and 2 hours of restraint stress, as well as after 1 hour of unimpeded movement in a
cage placed in the testing room. Restraint stress was effected through physical
confinement within plastic, cylindrical tubing. Female subjects underwent each of the
testing conditions twice, during periods of high and low endogenous estrogen exposure,
as ascertained by microscopic examination of vaginal epithelial cells for estrous cycle
stage determination. Females in proestrus (elevated endogenous estrogen exposure)
subjected to 1 hour of restraint performed significantly worse than their baseline scores
(p=0.0017) or females in estrus (low endogenous estrogen exposure) after 1 hour of
restraint (p=0.00014). After 1 hour of restraint, females in proestrus also committed an
increased rate of perseverative errors compared to females in estrus, although this
increase did not achieve statistical significance (p=0.06). No appreciable differences
existed among subject groups in baseline performance or subsequent to 2 hours of
restraint stress. Resultant data indicate impaired working memory among female rats
under conditions of stress in the context of elevated endogenous estrogen exposure. This
study, then, suggests a potential synergistic effect of stress and estrogen in compromising
prefrontal cortex function and, therefore, may lend insight into the observed sex-related
disparity in the incidence of major depressive disorder and other anxiety-related mood
disorders.
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Introduction
Mood disorders have a profound impact on both personal and collective outcome,
with Major Depressive Disorder (MDD) the most severe in terms of prevalence (15%)
and social cost ($40 billion per year) associated with disease morbidity (1). The
incidence of MDD among women is twice that among men, a differential that transcends
distinctions of race, ethnicity, and socioeconomic class and further, that is evident in
multinational epidemiologic data (2). However, despite the fact that depression is twice
as common among women as men, few experimental data exist regarding the
pathophysiology of depression specifically in women, including the potential importance
of estrogen in contributing to this phenomenon. Although this pronounced sex-related
differential could be partially attributable to sociocultural influences, the ubiquity of this
striking discrepancy suggests some component of biological predisposition. A potential
insight into this sex differential derives from the occurrence of specifically reproductiverelated mood disorders among women, including premenstrual syndrome and menopausal
depression. Such disorders demand consideration of the role of ovarian hormones in
creating a biological context that predisposes some women to mood disturbances.
Research to date has dispelled the possibility of a simple, causal relationship between
level of hormone exposure and the development of MDD or reproductive-related mood
disorders (3). Rather, extensive data collectively suggest the intricate interplay of
genetic, biological, and environmental factors in the generation of a particular
neurochemical milieu that predisposes some women to develop dysregulated mood states.
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Environmental context undoubtedly contributes to the pathogenesis of depression,
particularly as it produces sources of uncontrollable stress. As sociocultural forces
broadly may exert certain pressures uniquely upon women, they may partially account for
the sex-related variance in MDD incidence. Both epidemiological and genetic research
indicate considerable interrelatedness among stress, anxiety, and depression.
Epidemiologic data have demonstrated a strong association between stressful life events
and the development of depression (4). Moreover, the interaction between anxiety and
depression is reflected by the high incidence of co-morbidity of depressive and anxietyrelated mood disorders (5, 6). Further, animal models employed to simulate depression
involve “learned helplessness,” a state that develops in animal subjects after repeated
exposure to uncontrollable stress. The cognitive and behavioral impairment observed
among animals under stressful conditions, therefore, resembles that associated with
clinical depression, as well.

Genetics and Sex-Related Variance in Depression
Dispelling a purely environmental basis for this sex-related variance, however,
emergent evidence offers support for a prominent role of genetics in the development of
MDD. Linkage studies, for example, have suggested the potential involvement of cAMP
Response Element Binding 1 protein (CREB1) in the pathophysiology of MDD (7).
CREB1 is a transcription factor and represents a downstream target of an intracellular
signaling cascade mediated proximally by protein kinase A (PKA). This cascade is
coupled to many neurotransmitter receptors, and interaction has been reported between
CREB1 and nuclear estrogen receptors. The association between CREB1 and MDD,
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moreover, was observed exclusively among female probands, further supporting the
notion that susceptibility to mood disorders has a biological basis. CREB-based research
may yield further insights into the genetic predisposition toward MDD and the attendant
underlying pathophysiology of the disease. However, the precise mechanism whereby
differences in CREB phosphorylation might translate into mood disturbances remains
unelucidated.
Similar to these CREB-associated findings, differences in estrogen receptor-α (ERα) genotype were associated with the development of MDD, but also solely in women
(8). Moreover, at the level of transcription, discrepant amounts of ER-α mRNA
production have been observed in mental illness. Decreased ER-α mRNA levels were
found in the amygdala of patients with MDD compared to controls, and women with
MDD had diminished ER-α mRNA production in the dorsolateral prefrontal cortex (PFC)
and throughout the hippocampus, with mRNA levels significantly below those of men
with depression (9, 10).
These preclinical data, then, strongly suggest that vulnerability to mood disorders
is, to an extent, biologically encoded, and further implicate ovarian hormones in the
evolution of this vulnerability. To explore the degree to which ovarian hormones are
implicated in mood disorders, the relationship between ovarian hormones and cognition
requires examination. The influence of estrogen in particular has been established
throughout the brain, with roles in neuroprotective, learning, and memory functions,
among others. Critically, however, estrogen’s role in the brain must be examined
contextually, with a high degree of specificity for brain region and the associated facets
of cognition.
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Subcortical Effects of Estrogen
Ovarian hormones appear to effect structural changes in subcortical areas of the
brain. Choi et al (2003) showed that both estrogen and progesterone administration affect
the neuroanatomy of the CA1 region of the hippocampus, modifying dendritic spine
number and synaptogenesis (11). Granholm et al (2003) examined the effects of estrogen
treatment in a mouse model of Down Syndrome. Whereas non-treated mice exhibited
significant loss of hippocampal dendritic spines and cholinergic neurons, estrogen-treated
mice exhibited marked sparing of these losses (12). Furthermore, although estrogen did
not affect amyloid-associated protein (APP) levels in the hippocampus, data from the
same study demonstrated increased full-length striatal APP after estrogen treatment. This
posited neuroprotective role of estrogen finds additional support in the work of Gulinello
et al (2005), who found that estrogen administration decreased neuronal injury in the
hippocampus subsequent to global ischemic injury (13). This study moreover found an
associated preservation of visual and spatial memory, providing a functional corollary to
the anatomic observations.
Ovarian hormones further have been implicated extensively in subcortical
biochemistry and cognition. In a study conducted by Luine et al (2003), estrogen
administration was associated with improvement in visual and place memory, tasks
specific to hippocampal function (14). Rat data also demonstrate that estrogen augments
neuronal excitability in the hippocampus and increases acetylcholine release during
performance of a hippocampus-mediated task (15, 16). Increased NMDA receptor
activation in these regions also has been observed subsequent to estrogen administration
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(17). Estrogen further appears to interact with cholinergic neurons in the basal forebrain,
with similar, enhancing effects on learning (18, 19). Of note, estrogen-induced
enhancement of hippocampus-mediated cognition both augments acetylcholine release
and appears acetylcholine-dependent, specifically through the acetylcholine M2 receptor
(20). This observation attests to the complexity of estrogen’s effects in the brain, as
estrogen both creates and is dependent upon a particular neurochemical milieu to produce
functional, cognitive outcomes.
In addition to its interaction with cholinergic systems, estrogen interfaces with
serotonergic systems, as well. In a study by Rocha et al (2005), estrogen was shown to
increase serotonin production in the dorsal raphe nucleus (DRN) of mice, and attendant
antidepressant effects were observed (21). This increase in serotonin was ER-β
dependent, as the antidepressant properties of estrogen were absent in ER-β knockout
mice. Estrogen further mediates serotonin release through its modulatory role at the 5HT1A receptor, which is both pre- and post-synaptic and therefore integral to serotonin
signaling and negative feedback (22).
These data collectively support a significant role for estrogen in the brain, but the
estrogen-mediated effects they suggest cannot be assumed for the prefrontal cortex
(PFC). Research to date suggests that whereas estrogen enhances hippocampus-mediated
learning, it plays a profoundly different role in the PFC. In fact, emergent data indicate
that estrogen facilitates shifts in cognitive strategy toward hippocampus-mediated tasks
and away from striatal or prefrontal cognition (23, 24). Such data demand examination
of the relationship specifically between estrogen and the PCF, and they refute the broad
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application of a cognition-enhancing role for estrogen throughout the brain; facets of
cognition of highly region-specific, and so, too, appear the effects of estrogen.

The Prefrontal Cortex
The PFC warrants particular attention as a region of critical importance in the
pathogenesis of MDD. Current models of MDD posit the centrality of the PFC in disease
pathophysiology, a position that derives from the PFC’s unique capacity to
simultaneously manipulate information acquired from sources disparate in origin and
time (25). The PFC maintains the availability of information, permits the assimilation of
new information, and enables directed, focused attention that facilitates the translation of
accessible information into goal-directed behavior. In aggregate, these functions
constitute working memory, a defining function of the PFC, whereas animals with PFC
lesions exhibit perseveration, impairment in sustained attention, and absence of
behavioral inhibition. The interpretive, executive role of the PFC may also be understood
with regard to the regulation of mood and emotional state, as the PFC represents the
integrative and interpretive locus of limbic and sensory input, thereby determining
overarching experience and commensurate mood state. This model finds support in an
imaging study conducted by Levesque et al (2003), who recorded activation of different
areas of the PFC in the experience of sadness and the active suppression thereof (26).
Such data suggest that the PFC may be responsible for interpreting and re-interpreting
experience, to the extent that an initial emotional response may be overridden in
subsequent evaluation. Derailment of normal PFC function consequently would impede
this volitional, state-changing capacity, and yield consequent mood dysregulation.
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The primacy of the PFC in MDD pathogenesis is supported by abundant evidence
of PFC dysfunction associated with major depression. Depressive states are commonly
characterized by poor concentration, impaired motivational process, diminished verbal
fluency, and perseverative thoughts, all areas of cognition regulated by the PFC. Lesions
of the PFC similarly produce these deficits, suggesting perhaps that the pathophysiology
of MDD involves some neurochemical “injury” to the PFC. Patients suffering from
MDD moreover appear to exhibit cortical hypometabolism and diminished PFC volume
(27, 28). Whereas mood presents an elusive prefrontal product in animal studies,
working memory provides a surrogate for evaluating PFC function. A conceptual
assumption must then be adopted, that is, that impairment in PFC-mediated learning
corresponds to impairment in prefrontal mood regulation, and accordingly, that derailed
working memory predicts a state of vulnerability to the generation of a depressive
phenotype.
A critical relationship, then, emerges among the PFC, MDD, and stress, as stress is
associated with both PFC impairment and depression. In animal studies, stress has been
shown to cause diminished working memory function. This functional diminution has
been attributed to stress-related changes in PFC neurochemistry, including increased
release of norepinephrine (NE) and dopamine (DA); impairment in working memory
appears a product of the consequent increased stimulation particularly of the NE α-1 and
DA D1 receptors, with consequent signaling of IP3/PKC and cAMP/PKA pathways,
respectively (29). NE in particular is implicated in working memory impairment, as pretreatment with an α-2 receptor agonist has proven protective for PFC function (30).
Therefore, stress response has proven an important area of study for gaining insight into
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the pathophysiology of depression and for evaluating differential susceptibility to the
development of MDD. The question then arises as to the role of stress in mood disorders
specifically in women, and the potential modulatory effect of ovarian hormones on the
stress response, particularly as they interface in the PFC.

The PFC, Stress, and Estrogen
Substantial data exist supporting an influential role of estrogen on the primary
stress response. Sex-based disparities in corticosterone release have been observed in a
number of animal studies, in response to both acute and chronic stress (31).
Furthermore, in humans, a subset of corticotrophin-releasing hormone (CRH) neurons in
the hypothalamus are ER-α positive. Interestingly, a study by Bao (2005) et al found a
significantly increased number of ER- α positive CRH neurons in patients with MDD
(32).
Beyond this apparent interaction at the level of the hypothalamic-pituitary-adrenal
axis, estrogen and stress interface again in the PFC. The disproportionate incidence of
MDD among women and the centrality of the PFC in depression together demand
attention to the influence of ovarian hormones on PFC activity. Beyond their activity in
subcortical regions, ovarian hormones increasingly have been implicated in the mediation
of direct effects in the PFC in women. Berman et al (1997), for example, demonstrated
that progesterone and estrogen both were independently capable of changing regional
cerebral blood flow to the PFC during performance of a PFC-specific task (33). Estrogen
also appears to play a significant, modulatory role in the stress response specific to the
PFC. Rodent and primate research demonstrates that ovarian hormones are powerful
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regulators of cortical catecholamines, the neurotransmitters prominent in the stress
response (34, 35, 36). States of acute stress are characterized by catecholamine upregulation, including increased stimulation of the NE α-1 receptor and diminished
activation of the functionally protective α-2 receptor (37). Whereas low to moderate
levels of norepinephrine and dopamine are associated with optimal PFC function,
impairment in PFC-mediated cognition develops with elevated levels of these
catecholamines. Uncontrollable stress therefore constitutes a primary means by which
PFC function may be compromised, and estrogen is again specifically implicated in this
neurochemical picture, as it acts as a transcription factor for the cortical α-1 receptor (38)
and appears to cause relatively decreased stimulation of the α-2 receptor (39). The
literature consequently suggests a synergism between stress and estrogen, a collaborative
favoring of subcortical cognition at the expense of prefrontal, executive functions.
Confluent exposure to uncontrollable stress and estrogen must therefore be examined as a
potential contributor to the genesis of MDD, insofar as it creates a neurochemical context
that predisposes toward PFC derailment. PFC impairment indeed may have adaptive
utility as a response to acute stress, enabling more reflexive, primitive reactions to
emerge in response to a perceived environmental threat (40). However, chronicity of
uncontrollable stress, particularly in the context of endogenous estrogen exposure, could
produce a maladaptive state with prolonged PFC incapacitation and consequent mood
dysregulation.
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The Present Study
In aggregate, the elaborated data collectively underscore the importance of better
delineating the relationship among stress, the PFC, and ovarian hormones, and of
understanding this relationship with regard to its centrality in the sex-specific
development of MDD. This relationship was explored in a recent study by Shansky et al
(2004) which demonstrated the detrimental effects of estrogen exposure on performance
of a PFC-mediated task after administration of the pharmacologic stressor FG7142, a
benzodiazepine inverse agonist (41). Whereas female rats in states of low or absent
(post-ovariectomy) estrogen exposure exhibited no performance impairment after
FG7142 administration, female rats showed significantly compromised performance
when exposed to high levels of estrogen. The methodological question remains,
however, whether FG7142 as a pharmacologic stressor represents a valid approximation
of physiologic stress. To address this question, the present study selectively examined
the effects of estrogen on PFC function in rats after exposure to restraint stress. Restraint
stress has been demonstrated in rats to increase plasma corticosterone as well as
catecholamines, serotonin, and acetylcholine in the PFC of rats (42, 43, 44).
Furthermore, Nakane et al (1994) showed that norepinephrine remains elevated for 20
minutes in the PFC after subjects’ release from one hour of immobilization (45). Thus,
restraint stress has been well-established as a reasonable model for simulating the effects
of natural, uncontrollable stress. Resultant data from the present study corroborate the
hypothesis that estrogen indeed plays a modulatory role in PFC function subsequent to
restraint stress exposure. This study, then, provides further evidence that ovarian
hormones represent a critical, regulatory link between stress and PFC-mediated
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cognition. As mediators of the stress response, ovarian hormones thereby may confer
vulnerability to mood disturbance and contribute substantially to the sex-related variance
in depression.
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Hypothesis and Specific Aims of the Study
Hypothesis
The basis of the present study is the posited role of estrogen in establishing a
hormonal context of increased vulnerability to stress as demonstrated by PFC function,
quantified by performance on a spatial delayed alternation task. Diminished ability to
tolerate stress has been established as a predisposing factor for the development of
depression, and greater stress tolerance appears protective. The null hypothesis is as
follows: Estrogen does not play a modulating role in female rats’ response to stress as
measured by performance on a working memory task.

Specific Aims of the Study
The aims of the proposed study are as follows:

1.) To measure the response of male and female rats to restraint stress as a function of
performance on a spatial delayed alternation task.

2.) To demonstrate whether a sex-specific response to stress appear to exist in rats.
Specifically, the target of exploration is the whether male and female rats exhibit
differential working memory performance subsequent to restraint, regardless of estrous
cycle phase.

2.) To discern the presence or absence of a correlation between endogenous estrogen
level and stress response in female rats, that is, to determine if the proestrus phase of the
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estrous cycle (highest endogenous estrogen exposure) confers vulnerability to stress
and/or the estrus phase (lowest endogenous estrogen exposure) confers protective effects
from stress. Thus, the objective is to examine the potential interaction of estrogen
exposure and acute stress in altering PFC function.

4.) To determine the appropriateness of use of the pharmacological agent FG7142 to
simulate environmental stressors through comparison of their respective effects on PFC
activity. As various experimental forms of acute stress are available, this study may help
evaluate whether pharmacologic stress approximates the effects of physical stress on
working memory.

5.) To gather preliminary data for the eventual hypothesizing of a sex-specific
pathophysiology of depression in females, including the potential role of estrogen therein.
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Methods and Materials
The overall study design comprised three stages, those of habituation, training, and
testing. Habituation was essential for allowing study subjects to acclimate to the T maze,
accepting food rewards directly from an experimentor, and human handling.
Corresponding to these goals of acclimation, habituation was subdivided into three
phases. Once subjects were accustomed to moving throughout the maze, accepting
rewards, and manual transfer, they underwent training on a delayed alternation working
memory task. Training was deemed complete when a subject scored 60-80% on
consecutive testing days. Finally, during the testing stage, testing conditions were
manipulated; subjects performed the T maze task alternatively after 1 hour of restraint
stress, 2 hours of restraint stress, or 1 hour of unrestrained movement within a cage
placed in the testing room. The last of these manipulations constituted control
conditions.

Subjects
The subject population comprised male (n=8) and female (n=10) Sprague-Dawley
rats (Camm, Wayne, NJ). Subjects were housed singly and exposed to a 12-hour
light/dark cycle, with all testing conducted during the light phase. Subjects’ diet
consisted of Purina rat chow (15 g/day/rat), which was provided immediately after
cognitive testing. Water was available ad libitum. Food rewards were administered
during testing, and the choice of highly palatable miniature chocolate chips obviated the
need for dietary restriction. Over the course of the 10 month study period, male subjects’
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weights increased from a baseline mean of 240 g to 390 g. Female subjects’ weights
increased from a baseline mean of 240 g to 300 g.

Habituation
Subjects performed a delayed alternation task in a T maze (90 cm x 65 cm), which
also served as the site of habituation and training. Complete subject habituation was
considered achieved when an animal ate proffered chocolate chips directly from an
experimentor’s hand. Habituation occurred in three phases, with completion of each
stage requiring the subject to consume 10 chocolate chips within 6 minutes of entering
the T maze.
Upon initial introduction into the maze, each animal was permitted to explore
freely. The first stage was deemed complete when the subject consumed 10 chips placed
at the end of both arms of the maze; arm choice was unimportant. In the second stage,
animals were again allowed to choose either arm of the maze but acclimated to accepting
chips directly from an experimentor’s hand upon reaching the end of an arm. The third
phase of habituation introduced subjects to the experimentor’s manual return of the
animal to the maze starting gate after arrival at the end of a maze arm. Habituation to
handling was imperative, as handling could otherwise constitute an inadvertent source of
stress under intended unstressed conditions.

Estrous Phase Monitoring
The rat estrous cycle comprises 4 stages, and each stage is normally 24 hours in
duration. The proestrus phase is that of highest estrogen exposure, whereas the estrus
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phase represents a nadir of endogenous estrogen exposure. Female subjects were
vaginally lavaged with a cotton swab immediately subsequent to testing to determine
estrous cycle phase. Lavage specimens were placed on microscope slides and stained
with Cresyl violet. Specimens were then viewed by light microscopy to determine
estrous cycle stage. Proestrus is characterized on histology by nucleated vaginal
epithelial cells of irregular shape, often organized in clusters. Epithelial cells consistent
with estrus may also be of irregular shape but are non-nucleated and generally organized
singly. Estrous cycle phase determination was employed to select candidates for testing
the following day, based on the expected cycle phase. Subjects were lavaged again after
testing to ensure cycle phase had been predicted accurately. This measure was
particularly important, as stress can contribute to estrous cycle irregularity.
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Figure 1. Histologic Determination of Estrous Cycle Phase

PROESTRUS

ESTRUS
Figure 1. Photograph of vaginal epithelial cells characteristic of proestrus and estrus.
Borrowed from Marcondes FK, et al (Braz J Biol vol 62 no.4a Sao Carlos Nov 2002).

Cognitive testing
A delayed alternation task was employed to examine spatial working memory. In
addition to working memory, completion of the selected task demands behavioral
inhibition and sustained attention. Performance is therefore interpreted as a measure of
PFC function, an interpretation supported by data demonstrating impaired task
performance in animals with compromised PFC function. This impairment has been
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observed in animals with mechanical PFC lesions as well as those exposed to the
pharmacologic stressor FG7142, an agent known to affect the PFC (46).
A period of training on the delayed alternation task followed completion of all 3
phases of habituation. Subjects initially were placed in the maze’s gated start area and
permitted free movement throughout the maze upon the gate’s opening. Once the animal
selected one arm of the maze, it received a food reward regardless of the side chosen.
The animal then was returned manually to the start area behind the closed gate. On all
subsequent trials, the subject was rewarded only if it selected the arm opposite from that
which it had selected on the previous trial. If an animal committed an arm selection
error, it was returned to the start area without reward. A total of 10 trials, not including
the subject’s initial arm selection, constituted a single testing session. Both test
completion time and percentage of correctly performed trials were recorded. Animals
were tested once daily, 5 days a week, and testing was conducted at the same time each
day.

Scoring
Performance data were recorded as the percentage of trials during which the
appropriate maze arm was selected. Therefore, a score of 50% corresponds roughly to
chance, and scores below 50% indicate perseveration and impaired performance. An
animal was deemed appropriate for restraint after achieving scores between 60-80% on 2
consecutive days of testing. On the third day, all male subjects were considered
candidates for restraint. Female subjects were restrained only if vaginal lavage suggested
they would be in either estrus or proestrus, the 2 cycle stages of interest, on the day of
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restraint. Female subjects thus potentially could be tested under 6 different testing
conditions. However, due to a variety of circumstances, not all data points were collected
for each animal.

Inter-trial delay
Between trials, subjects experienced a brief delay. Initially, the inter-trial delay was
minimized, of duration adequate only for the previously selected arm to be cleansed with
alcohol (~ 2 sec). Cleansing was performed to eliminate the potential influence of
olfactory cues on subsequent arm choice. If a subject scored 80% or higher on
consecutive days, the inter-trial delay was increased by 5 seconds. The delay was
continually raised by 5 second increments as needed to maintain average scores no higher
than 80%.

Restraint
Prior to testing, subjects were confined to a plastic restraint tube variably for 1 hour
or 2 hours. Control conditions consisted of the subject remaining unrestrained in its
home cage in the testing room for 1 hour prior to testing. The order in which subjects
underwent the various testing conditions (3 total for males, 6 for females) was
randomized. Furthermore, testing sessions done subsequent to restraint were separated
temporally by at least one week for any individual subject in order to minimize the effect
of habituation to restraint on performance outcomes.
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Statistical Analysis
Mean performance was determined for each of the three subject groups (males,
females in proestrus, females in estrus) for each of the three testing conditions (control, 1
hour of restraint, 2 hours of restraint). T test analysis was employed to determine
statistical differences within each subject group across any 2 testing conditions. T test
analysis was similarly used to determine differences between 2 subject groups under the
same testing condition. Repeated measures ANOVA was utilized to identify significant
variance in performance across subject groups and within subject groups under
alternative testing conditions. Mean number of perseverative errors and mean task
completion times were also calculated for all subject groups across testing conditions.
Pearson R values were calculated to determine any association between perseveration and
time required to complete the task. In addition, ANOVA was employed to detect
differences in task completion time across subject groups and testing conditions. If
significant variance was found, tests of effects were performed to identify the specific
source(s) of variance. Finally, ordinal values were assigned to each testing condition, and
T test analysis was utilized to evaluate any incidental patterns in testing order.

My responsibilities
My responsibilities in the present study involved cognitive testing of female subjects.
Subjects had completed maze habituation immediately prior to the onset of my
participation and were at variable stages of learning the task; some subjects were
immediately ready for testing, whereas others required a longer learning phase. On a
daily basis, I conducted delayed alternation task testing with each of the 10 female rats. I
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administered rewards and recorded each subject’s respective performance with regard to
overall score and task completion time.
Subsequent to task completion, I provided each animal with a daily ration of rat
chow. When all subjects completed testing, I performed vaginal lavage on all animals for
estrous cycle stage determination. I prepared all specimens and examined them by light
microscopy. Subjects expected to be in estrus or proestrus the following day were
identified as candidates for formal testing, either under control conditions or following
restraint stress. After a subject underwent formal testing, I again lavaged the animal in
order to confirm an accurate prediction of estrous cycle stage. In the event of a
discrepancy between predicted and actual phase, performance data were discarded.
I entered performance data daily in spreadsheets and maintained a log of estrous
cycle stage for each subject. After all performance data were collected, I participated in
the analysis of acquired data from all subjects, both male and female.
I did not contribute to the processes of protocol development or subject habituation,
nor was I involved in the training or testing of male subjects. After my involvement in
data collection ceased, another study participant performed additional cognitive testing of
the female subjects to augment the data set.
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Results
PFC function was measured as a function of performance on the T-maze task, a
delayed alternation task. After initially selecting one arm of the maze, the subject was
required to choose the opposite arm on the subsequent trial and to continually choose
alternating arms for a total of 10 trials, excluding initial arm choice. Performance was
quantified as a percent of correctly performed trials, those for which the subject
alternated its choice of maze arm.

Performance
Baseline Performance
In the absence of restraint stress, T-maze performance was comparable across
subject groups. The mean scores achieved respectively by males, females in estrus, and
females in proestrus were 75% (n=8, SD+/-5.3, SEM+/-1.9), 73% (n=9, SD+/-7.1,
SEM+/-2.4), and 70% (n=6, SD+/-8.9, SEM+/-3.7). As analyzed by T test, no
appreciable differences in performance existed between males and females in estrus
(p=0.6), males and females in proestrus (p=0.2), nor between females under high and low
estrogen exposure (p=0.4).
Performance following 1 hour of restraint stress
Subsequent to 1 hour of restraint stress, performance among both males and females
in estrus showed no significant change from that achieved in the control trials (p=0.6 for
males, p=0.9 for females in estrus). Among males, the mean score after restraint was
71% (n=8, SD+/-19.6, SEM+/-6.9), with the considerable standard deviation largely
attributable to 2 outlying scores of 40% and 100%. The mean score among females in
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estrus was 74% (n=9, SD+/-11.3, SEM+/-3.8), which actually represented an
improvement over baseline performance. Females in proestrus, however, exhibited a
significant decline in performance outcome as compared to control conditions
(p=0.0017), with a mean score of 50% (n=10, SD+/-10.5, SEM+/-3.3) (Fig. 1).
Furthermore, after 1 hour of restraint, females in proestrus performed significantly worse
than females in estrus (p=0.00014). ANOVA with repeated measures demonstrated a
significant between subjects effect (F [2,14] = 6.14; p<0.01) and within subjects effect of
restraint (F [2,14] = 7.31; p<0.003). Analysis revealed a significant interaction between
estrogen status and performance only after 1 hour of restraint (F [2,14] = 14.0;
p<0.0005), whereas no appreciable effect of estrogen status on performance was
observed under control conditions or subsequent to 2 hours of restraint (p>0.1).
Performance following 2 hours of restraint stress
After 2 hours of restraint, performance suffered among both the males and the
females in estrus. As compared to performance under control conditions, the decline for
males reached statistical significance (p=0.01) with a mean score of 58% (n=5, SD+/14.8, SEM+/-6.6). The mean score for females in estrus was identical to that of the males
at 58% (n=4, SD+/-18.9, SEM+/-9.5). This, too, constituted a significant impairment
compared to baseline performance (p=0.04). Among females in proestrus, the mean
score was 60% (n=6, SD+/-12.6, SEM+/-5.2); although scores among females in
proestrus remained depressed compared to baseline performance, they did not differ
significantly from those achieved after only 1 hour of restraint (p=0.11), and were
strikingly similar to those among males or females in estrus after prolonged restraint.
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Figure 1. Task performance following restraint stress.
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Figure 1. Performance data for all three subject groups across various study conditions.
Y-axis values represent mean percentage of correctly performed trials. No significant
differences in performance were evident under control conditions, nor after 2 hours of
restraint stress. However, after 1 hour of restraint, females in proestrus demonstrated
significant impairment in working memory, whereas males and females in estrus were
not similarly impaired.
* - denotes significance
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Perseveration
Perseveration was quantified as the maximum number of consecutive trials in a
single testing period during which a subject selected the same arm of the maze. The
mean number of perseverative errors committed by males in the absence of restraint
stress was 2.3 (n=8, SD+/-0.46, SEM+/-0.2), and errors were committed at a comparable
rate by females in both estrus and proestrus, with means of 2.6 (n=8, SD+/-0.74, SEM+/0.3) and 2.4 (n=5, SD=/-0.6, SEM+/-0.3), respectively (Fig. 2).
After 1 hour of restraint, males and females in estrus achieved the same mean error
rate of 2.5 errors (n=8, SD=/-0.8, SEM+/-0.3 for both subject groups) for each testing
session. Females in proestrus, however, committed an average of 4.1 errors (n=9, SD+/1.3, SEM+/-0.4). As evaluated by T test, the greater perseveration rate evident among
females in proestrus after 1 hour of restraint did not achieve statistical significance.
However, a trend toward increased perseverative error was observed among females in
proestrus compared to females in estrus when both groups were tested subsequent to 1
hour of restraint stress (p=0.06).
After prolonged restraint, this disparity in perseverative error rate among subject
groups disappeared. Males committed a mean error number of 3.2 (n=5, SD+/-0.84,
SEM+/-0.4) after 2 hours of restraint, and the average perseverative error rate was 3.3 for
both females in estrus (n=4, SD+/-1.3, SEM+/-0.7) and females in proestrus (n=3, SD+/2.3, SEM+/-1.6).
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Figure 2. Perseverative Error Rate
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Figure 2. Mean number of perseverative errors committed across subject groups under
different testing conditions. Y-axis represents mean number of errors for each testing
session. Although no disparities in error rate achieved statistical significance, a trend
toward increased perseveration among females in proestrus exposed to 1 hour of restraint
stress was observed.
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Task Completion Time
Task completion time was defined as the time elapsed between a subject’s release into the
T-maze and its final selection of maze arm upon completion of 10 alternating trials.
Inter-trial delays were subtracted from time-to-finish values for those rats with inter-trial
delays of 5 seconds or longer. T test analysis revealed an association between time-tofinish and testing condition exclusively among males, who completed the T maze task
significantly faster when unrestrained than after 1 hour of restraint (p=0.02). No
comparable association characterized task completion time among unrestrained and
restrained females in estrus (p=0.09) or proestrus (p=0.66). Repeated-measures ANOVA
revealed no between subjects effect of estrogen status on task completion time.
However, a significant within subjects effect of restraint stress was observed (F [2,13] =
6.8; p<0.005). This result appears consistent with a freezing response subsequent to
restraint stress. A small but significant interaction was identified between estrogen status
and restraint (F [4,26] = 3.14; p=0.03), which tests of effects revealed to be a product of
differences in task completion time under control conditions, with males completing the
task faster than females (F [2,13] = 3.19; p=0.075). No significant differences in task
completion time were observed across subject groups subsequent to either 1 or 2 hours of
restraint (p=0.63, p=0.48).
Finally, Pearson R values were calculated to assess a possible association between
perseveration and time-to-finish. This analysis was performed to evaluate the possibility
of increased error rate representing an artifact of longer test completion times. If females
in proestrus simply performed the task more slowly, they would assume a greater
working memory burden to achieve comparable scores; each previous choice of maze
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arm would have to be stored accessibly for a longer duration. However, no such
association between task completion time and error rate existed for female subjects under
any testing condition (R values ranged between -0.28 and 0.34). To the converse,
females in proestrus had shorter task completion times after both 1 and 2 hours of
restraint stress than their estrus-phase counterparts. Among males, a trend toward a
positive correlation between task completion time and error rate was observed (R value =
0.67; p>0.05 for all other R values) (Table 1).
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Table 1. Task Completion Time and Error Rate

Subject Group

Mean Time (min)

Mean Errors

Pearson R Value

Control/Estrus

4.3

2.6

0.19

Control/Proestrus

4.7

2.4

0.23

Control/Males

1.8**

2.3

0.44

1 Hour/Estrus

5.8

2.5

0.34

1 Hour/Proestrus

5.3

4.1*

0.15

1 Hour/Males

4.5

2.5

-0.14

2 Hour/Estrus

4.8

3.3

-0.10

2 Hour/Proestrus

3.8

3.3

-0.28

2 Hour/Males

5.0

3.2

0.67*

Table 1. Task completion times and mean errors committed by subjects across testing
conditions. Male subjects completed the task significantly faster under unstressed
conditions than following restraint stress. Among female subjects, no significant
differences were evident in time-to-finish or perseverative error rate, although a trend
toward increased error commission was observed among females in proestrus subject to 1
hour of restraint stress. No significant correlations existed between task completion time
and perseverative error rate.
* - denotes trend
** - denotes significance
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Testing order
The order in which rats were exposed to various testing conditions was assigned
randomly for individual subjects. Subjects potentially could habituate to restraint stress,
so a consistently applied sequence of testing conditions might inflate performance under
conditions tested later as compared to those tested initially, rather than reflect an
estrogen-mediated effect. To ensure that no pattern incidentally emerged among female
subjects, ordinal values (1-6) were designated for each testing condition (control, 1 hour
of restraint, 2 hours of restraint in estrus or proestrus) according to the order in which a
given subject had been tested. T test analysis of ordinals revealed no significant
association between the timing of exposure to 1 hour of restraint stress and estrous cycle
stage at the time of exposure (p=0.12).
Male subjects were assigned ordinal values of 1-3 corresponding to testing
conditions. No significant pattern of testing order was observed.
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Discussion
The results from this study underscore the importance of context in estrogenmediated effects on cognitive function. Whereas no significant differences in task
performance existed among subject groups at baseline, female subjects in proestrus
exhibited marked impairment in working memory after 1 hour of restraint stress. This
observed decline in score corresponded to an increased rate of perseverative errors, and it
further did not appear to be an artifact of differences in task completion time or testing
order. However, in the absence of restraint stress, female subjects in proestrus
performed comparably both to females in estrus and to males, demonstrating that
estrogen exposure alone was not sufficient to impair PFC function.
Of note, no discrepant performance was observed between females in estrus and
males subsequent to restraint stress. This comparability of performance is essential for
establishing that no baseline, sex-related differential in stress response existed among
study subjects. Any baseline differential would obscure distinctions between cognitive
effects secondary to estrogen exposure and those potentially due to other sex-based
differences in stress response. Multiple studies, for example, have reported disparate
corticosterone release in male and female rats, and corticosterone augments the stress
response in the PFC by down-regulating catecholamine transporters, augmenting the
detrimental effects of NE α-1 receptor binding. Thus, if corticosterone appeared to exert
independent effects on PFC function, it could prevent the effective isolation of estrogen
exposure as an experimental variable. Clearly, however, the absence of a baseline
differential does not preclude a contributory role of corticosterone in PFC impairment,
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and synergism between estrogen and corticosterone represents an important object of
future investigation.
Resultant data, then, support the role of elevated endogenous estrogen in impairing
PFC function, but exclusively under conditions of acute stress.

Limitations of the Study
Interpretation of data from the present study must be rendered with consideration of
several potential sources of error. Perhaps most important, the role of progesterone in the
acquired results merits attention. Progesterone, too, has prominent albeit as yet poorly
delineated activity in the brain. Furthermore, available data refute the simplistic
conceptualization of progesterone as merely counter-regulatory balance for estrogen.
Data from Tanabe et al (2004), for example, identify the capacity of progesterone
replacement alone to restore spatial working memory after the development of
scopolamine-associated cognitive deficits in rats (47). These data are consistent with
prior studies suggesting both neuroprotective and antidepressant properties of
progesterone. In the absence of scopolamine administration, however, data from the
same study indicate that isolated progesterone replacement was not sufficient to generate
improved spatial memory function, whereas such improvement was observed with either
estrogen alone or estrogen and progesterone replacement. Additional studies of
ovariectomized animals also demonstrate the ability of estrogen to independently effect
changes in cognitive function and stress response (48). Therefore, for purposes of the
present study, ample evidence exists to support the interpretation of resultant data as a
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reflection of differential estrogen exposure. The concomitant role of progesterone,
however, clearly merits further exploration.
A benefit of this study’s methodology also poses a potential shortcoming. All data
were gathered exclusively under exposure to endogenous estrogen, thus assuring
physiologic accuracy of both hormone form and exposure levels. However, estrogen
exposure consequently was not standardized across subjects, as opposed to studies of
ovariectomized subjects with subsequent, exogenous estrogen administration. Therefore,
the states of high and low estrogen exposure were relative constructs rather than absolute,
quantifiable variables. Similarly, the degree of flux of endogenous estrogen exposure
undoubtedly varied across subjects. To mitigate the effect of this variability on results,
each individual served as its own control, with each subject tested under as many
experimental conditions as possible. Furthermore, as the complete absence of estrogen
does not characterize normal physiology, the methodology employed may better
approximate naturally occurring interactions between variable estrogen exposure and
acute stress response.
As with any experiment, limitations of subject number present a potential challenge
to data interpretation. Each subject serving as its own control partially attenuated the low
overall subject number; however, due to a variety of circumstances, not all female
subjects underwent all six potential testing conditions. Though a conceivable weakness
of the study, this would in fact be more likely to obscure significant, estrogen-mediated
effects rather than to indicate a significant effect where none exists. The generation of
significant findings, therefore, actually may reflect the strength of estrogen’s role in
prefrontal cognition and stress response rather than an insufficiency of subjects.
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Subject habituation to restraint stress also may have impacted performance data.
Habituation could occur in the short term, enabling some waning of an acute stress
reaction over more prolonged periods of restraint. Working memory deficits evident
across all subject groups after 2 hours of restraint, however, argue against this process.
Conversely, under conditions of sufficient stress, elevated estrogen exposure may prove
unappreciable, a nominally additive effect. Such a phenomenon might underlie the
absence of a statistically significant difference in task performance between females in
estrus and proestrus after 2 hours of restraint. Whereas significant impairment was
observed exclusively in the proestrus group after 1 hour of restraint, cognitive
performance suffered uniformly across subject groups subsequent to 2 hours of restraint.
Also meriting consideration, long-term acclimation to restraint may have affected
resultant data; restraint stress might be expected to produce more severely impaired
performance earlier in the study period when restraint constituted a novel stress.
Conceivably, then, a decline in performance attributed to greater estrogen exposure
actually would reflect the incidental testing of animals in proestrus sooner than in estrus.
To address the potential confounding effects of long-term habituation, testing order was
analyzed using an ordinal system, and no significant pattern of testing order was evident.
Therefore, a substantial effect of habituation on testing outcome appears unlikely.
Finally, characterization of testing conditions as high or low endogenous estrogen
exposure was predicated on histologic interpretation of vaginal lavage specimens. If
epithelial cells were not definitively consistent with a particular estrous cycle phase, no
assignment of cycle stage was made, and lavage was repeated on the following testing
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day. Though an unlikely source of error, the identification of estrous cycle phase
remained subject to inaccurate interpretation.
Despite these potential limitations of the study, resultant data nonetheless provide
striking evidence of a detrimental effect on working memory associated with concomitant
exposure to acute stress and elevated endogenous estrogen. A mechanistic understanding
of estrogen’s influence on brain neurochemisty is continually improving, with available
animal data demonstrating direct relationships between estrogen and norepinephrine,
serotonin, dopamine, acetylcholine, and corticosterone. Of critical importance will be the
further delineation of estrogen’s interaction with other neurotransmitters specifically
within the PFC, as this region is most centrally implicated in the pathogenesis of MDD.
Consequently, the elucidation of estrogen’s role in the PFC requires a perspective of
dynamism, the incorporation of a number of critical variables that will produce different
functional or behavioral phenotypes. Contextual variables that merit discussion include
the brain region subject to estrogen release; environmental factors, particularly with
respect to stress as it affects neurotransmitter activity; and temporal variables, include
both timing of estrogen exposure and stage of physiologic development. Importantly,
exploration of these variables relies predominantly on animal studies, and, therefore, even
an exhaustive discussion of research to date cannot address perhaps the most critical
question, that of the degree to which these and similar data are applicable to human
models of MDD and estrogen’s role therein.
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Brain Region Specificity
The data from the present study underscore the context-dependent nature of
estrogen-mediated activity in the brain. Consequences of estrogen exposure first must be
considered in terms of regional specificity. Particularly with regard to the hippocampus,
estrogen produces neuroprotective and cognitive-promoting effects. In addition to data
previously cited, Leuner et al (2004) found high doses of estrogen to confer improved
associative memory in ovariectomized rats (49). Similarly, data from Bodensteiner et al
(2005) showed that estrogen administration was associated with decreased perseveration
and improved spatial memory in rats performing a Morris water maze task (50). Other
examples of estrogen’s cognition-enhancing effects specific to the hippocampus abound
in the literature (51, 52, 53). In striking contrast, the present study indicates estrogeninduced impairment of working memory, a prefrontal cognitive modality, and estrogen
moreover has been associated with diminished striatal cognition. In an effort to examine
estrogen’s role across cognitive strategies directly, Davis et al (2005) recently compared
hippocampal and striatal learning in ovariectomized rats. Resultant data demonstrated
estrogen-induced enhancement of place learning but not response learning, thus
supporting a hippocampus-specific benefit of estrogen replacement (54). These results,
then, provide direct evidence of the importance of regional context in understanding
estrogen’s effects on learning and memory. Further supporting this perspective, data
from Korol et al (2004) demonstrate that estrogen exposure causes shifts in learning
strategy in rats, with higher estrogen levels favoring hippocampus-mediated learning and
lower estrogen levels favoring striatal learning strategies. Increased estrogen was
associated with decreased GABA signaling in the hippocampus, and the authors posit that
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the consequent, diminished inhibitory tone enhances place learning, a hippocampal
cognitive function. These shifts in learning strategy were observed under both exogenous
and endogenous variant estrogen exposure, occurring not only in ovariectomized rats
with estrogen replacement but also in naturally cycling subjects; animals preferentially
employed place learning during proestrus and response learning during estrus. Despite
these shifts in strategy, however, no differences in absolute learning ability were
observed (55, 56). From a purely teleological perspective, an estrogen-mediated effect
on learning strategy appears adaptive, as learning and memory imperatives vary across
the reproductive cycle with the respective demands of mating, pregnancy, and the postpartum.
An additional contextual variable that merits attention is degree of estrogen
exposure. Many available data derive from studies employing exogenous estrogen
administration, though no universal, ideal concentration of estrogen replacement has been
established. Similarly, methodologies that involve endogenous estrogen exposure suffer
from lack of standardized exposure across subjects. For the interpretation of these data,
dopamine activity in the PFC may prove instructive. Dopamine receptor (DR) activation
is characterized by an inverted “U” effect on working memory performance, with
cognitive impairment evident at both extremes of DR-1 stimulation (57). Working
memory may prove contingent on an inverted “U” model of ER activation, as well, so
experimental outcomes may vary with the concentration of administered or endogenous
estrogen.
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Estrogen, Time, and Stress
The importance of temporality is highly relevant to estrogen exposure, as well, with
regard to both the pattern of estrogen administration and the timing of exposure during
the course of physiologic development. Work by Gulinello et al (2005) provides
impressive evidence for the influence of timing on outcome of estrogen administration.
Estrogen was delivered both acutely and chronically after precipitation of global ischemic
brain injury in female rats. Acute estrogen administration was associated with increased
survival of neurons in the CA1 region of the hippocampus but did not confer protective
effects on spatial memory. In contrast, long-term estrogen therapy appeared to protect
both spatial and visual memory. (58)
Data from Hodes and Shors (2005) further support the importance of time in
estrogen-related effects with regard to developmental stage. The observed differential
stress response in male and female rats was specific to adult animals and did not
characterize pre-pubertal animals (59). Echoing this theme, estrogen was associated with
deficits in both visual discrimination performance and spatial memory when administered
to pre-pubertal rhesus monkeys (60). The promoting effects of estrogen on hippocampal
cognition, then, appear particular to physiologically appropriate exposure, as premature
exposure conferred detrimental effects. Of additional interest, the data from this study
suggest that the acquired cognitive deficits endured beyond the period of exogenous
estrogen exposure. Thus, estrogen is implicated not only as an agent of immediate
influence on learning but also one responsible for long-term modeling of cognitive
function. Importantly, these data pertain to the hippocampus rather than the PFC;
however, they powerfully suggest the consideration of temporal variables in further
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exploration of the relationship between estrogen exposure and the PFC. Critically, then,
data from the present study must be understood as contextually pertinent to the adult,
reproductive stage of life, with variable estrogen exposure that is physiologically
appropriate as determined by the estrous cycle.
The influence of estrogen is not merely region-specific and time-dependent; a
critical consideration, too, is the concomitant presence of stress and the timing, severity,
and perceived uncontrollability thereof. The work of Shors et al (1998) lends support for
the state-dependent importance of estrogen in learning and memory; although the data
indicate that estrogen appears to promote associative learning in an unstressed state,
estrogen exposure was correlated with impaired learning after an acute stress in female
rats (61). A different relationship between estrogen and stress appears relevant to the
PFC. In the present study, estrogen exposure alone had no significant effect on working
memory. However, when estrogen and an acute stress response were confluent in the
PFC, a substantial impairment in cognitive performance was observed. Thus, whereas
stress appears to derail an otherwise enhancing effect of estrogen on hippocampal
cognition, estrogen and stress effect a synergistic diminution in prefrontal cognitive
ability.
Stress, however, cannot be viewed as a singular contextual variable, but rather must
be characterized further with regard to pattern of stress exposure and the perceived
degree of controllability of the stressor. Epidemiologic data specifically implicate
chronic stress exposure and a high degree of perceived uncontrollability as risk factors
for the development of MDD. Acute stress triggers catecholamine and corticosterone
release in rats, and although these neurotransmitters may remain elevated even after the
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removal of the stressor, they return to pre-stress levels soon thereafter (62).
Correspondingly, in the present study, female subjects exhibited impaired working
memory during proestrus immediately following restraint; however, on subsequent trials,
these animals fully recovered their baseline performance. In contrast to acute stress,
prolonged stress exposure has the capacity to effect long-term changes in
neurotransmitter signaling; with sufficient time, stress can mediate remodeling processes
associated with neuronal plasticity. These remodeling processes have been demonstrated
clearly in the primary stress response. Recently, Bhatnagar et al (2005) published
evidence of the effect of prenatal exposure to stress on long-term conditioning of the
stress response, data that moreover demonstrated a sex-based differential in conditioning
outcome (63). Indirect evidence supports a comparable plasticity in the hippocampus in
response to chronic stress exposure, as well. Leuner et al (2004) found that under
conditions of persistent, uncontrollable stress, female rats recovered performance of a
hippocampus-mediated task with long-term fluoxetine treatment; recovery of baseline
performance was not observed with acute treatment alone (64). The unique benefit of
long-term treatment suggests the undoing of a remodeling process effected by chronic
stress exposure. Of note, the same study demonstrated the profound significance of
perceived uncontrollability in stress exposure, as the ability to control a stressor
successfully mitigated the otherwise detrimental effect of stress on learning in female
subjects. With regard to the present study, then, the question arises as to whether a
sustained impairment of PFC function would be observed under conditions of chronic,
uncontrollable stress, as with daily confinement of subjects to the restraint tubing. Such
investigation would more closely approximate the posited relationship between chronic
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stress and MDD; mood disorders tend not to emerge after a single, episodic stressor but
rather under conditions of prolonged stress with the perception of uncontrollability. Time
is essential not simply for stress to generate an instantaneous neurochemical milieu, but
rather to potentiate differential responses to subsequent, stressful stimuli by means of
neuronal network remodeling.
Again, such studies underscore the necessity of viewing the interaction between
stress and cognition in a highly contextualized framework. Stress has been demonstrated
both to improve and derail facets of cognition, with variable results contingent on the
particular cognitive task and associated brain region, the timing and severity of the
stressor, and the degree of perceived uncontrollability of the stressor.

Conclusion
The immediate application of animal data to humans is clearly inappropriate, but
evidence derived from human studies does appear to recapitulate the basic themes
emerging from animal research. Specifically, these data collectively support the interface
of estrogen and the stress response in the PFC, with functional outcome variably
determined by duration of stress, degree of perceived uncontrollability of the stressor,
stage of physiologic development, and level of estrogen exposure. In conclusion, then,
data from the present study offer further support for a model of differential susceptibility
to mood disorders; such disorders certainly cannot be explained by simplistic models of
derangements in hormone levels but rather develop from the intricate interaction of
ovarian hormones and environmental exposures within a plastic neuronal framework.
Despite its remarkable complexity, this model of differential susceptibility nonetheless
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offers certain thematic interactions that may inform subsequent research. Among these
fundamental themes are estrogen’s region-specific activity in the brain, synergism
between estrogen exposure and the stress response in the PFC, and the importance of
variables of time, including duration of estrogen or stress exposure and stage of
physiologic development. The present study provides substantial evidence of the
functional importance of estrogen and the stress response when confluent in the PFC.
Continued exploration of the impact of ovarian hormones on prefrontal cognition will
undoubtedly promise further insights into the sex-related variance in the prevalence of
MDD and other mood disorders.
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